Infinity Pharma (INFI) Tops Q3 EPS by 47c

November 9, 2016 4:49 PM EST
Get Alerts INFI Hot Sheet
Trade INFI Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Infinity Pharma (NASDAQ: INFI) reported Q3 EPS of ($0.39), $0.47 better than the analyst estimate of ($0.86).

At September, 2016, Infinity had total cash, cash equivalents and available-for-sale securities of $112.3 million, compared to $146.4 million at June 30, 2016.

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment